In 1986, a delegation from a German equipment maker walked into an unremarkable office building in Charlotte, North Carolina. Only twenty-two people worked in it. There was no executive dining room, no corporate jet, no chief technology officer and no R&D department. The man waiting for them, Ken Iverson, was about to commit roughly the entire net worth of his company to a casting technology that had never been run at commercial scale. A hundred companies' engineers had inspected the same machine. It took eight years for a single competitor to follow him. This episode is about why. Not the technology — the operating system underneath it. Four layers of management between the furnace floor and the chief executive. A weekly operating review of a Fortune 500 manufacturer that fitted on five sheets of paper. A production bonus with no cap that ran 80 to 150 per cent of base wage, paid weekly, on a standard that was never allowed to move. And a pain-sharing rule that cut the chief executive's pay by three times the percentage taken from the man at the furnace. We also do the arithmetic that most Nucor stories skip: what the same three decades did to Bethlehem Steel, and what it cost ninety-five thousand pension participants.Then the uncomfortable third act. In 1999 Nucor's board removed Iverson and, six months later, his successor, over a strategy the board wanted and the founders called heresy. Nucor then spent twenty-five years executing every item on that list, and it worked.

Sources

• Nucor Corporation, corporate history timeline, nucor.com
• Nucor 10-K, FY2025 (net sales, shipments, mill capacity, West Virginia project)
• Nucor Annual Report to Stockholders, FY2025 (headquarters headcount, decentralised structure)
• Nucor 10-K, FY2022 and FY2009
• Nucor proxy statements (DEF 14A), FY1998, FY2002, FY2020, FY2025 (Senior Officers Incentive Plans, earnings base history, compensation philosophy)
• Nucor quarterly earnings releases, Q1 2025 through Q2 2026
• Nucor 8-K investor exhibits, 2026 (capital allocation, balance sheet)
• Nucor Corporation (B), Tuck School of Business at Dartmouth, case 2-0016
• Ken Iverson with Tom Varian, Plain Talk: Lessons from a Business Maverick, John Wiley & Sons, 1998
• Jim Collins, Good to Great, 2001

Send us Fan Mail

Operational Velocity is for education and general information only and is not investment, financial, legal, or tax advice, and nothing in it is a recommendation to buy or sell any security. The views expressed are the host's own, the company and figures discussed are drawn from public sources believed reliable but not guaranteed, and you should do your own research and consult a qualified professional before making any decision.

An eye surgeon in southern India sits between two operating tables. She finishes one cataract operation, turns ninety degrees, and starts the next on a patient who is already prepped and waiting. Six to eight operations an hour, against a conventional norm closer to one. They did not make the surgery faster. They removed the waiting. That single design choice is the seed of an operating system that now performs three quarters of a million procedures a year, gives away roughly half of them, funds itself without donors, and records infection rates of two per ten thousand cases. In this episode, Gautam examines Aravind Eye Care System: the constraint analysis Dr. G. Venkataswamy ran in 1976, the lens factory they built when a supplier's price capped the mission rather than the margin, the three-tier price list with no means test, the workforce they had to manufacture because the market didn't supply it, and the decision to teach the entire model to their competitors. Plus the question this show keeps returning to: does the operating system survive its architect? Aravind is the one case with twenty years of data on the other side of the founder's death.

Sources

• Aravind Eye Care System, Activity Report April 2024 – March 2025 https://aravind.org/wp-content/uploads/2025/09/Activity-Report_2024-2025_Final.pdf
• Gupta S, Ravilla RD, Aravind H, Chandrashekharan S, Ravilla TD. "Changing patterns in cataract surgery indications, outcomes, and costs, 2012–2023." Lancet Regional Health Southeast Asia, 2025 https://pmc.ncbi.nlm.nih.gov/articles/PMC11787026/
• Narang P, Ravindran R, Ravilla T, et al. "Allied Ophthalmic Personnel: Backbone of Aravind's Eye Care and Social Mission." Eye, 2026 https://www.nature.com/articles/s41433-026-04249-y
• Le HG, Ehrlich JR, Venkatesh R, et al. "A Sustainable Model For Delivering High-Quality, Efficient Cataract Surgery In Southern India." Health Affairs, 2016 https://pubmed.ncbi.nlm.nih.gov/27702949/
• Haripriya A, Chang DF, Ravindran RD. "Endophthalmitis reduction with intracameral moxifloxacin… results from 2 million consecutive cataract surgeries." J Cataract Refract Surg, 2019 https://www.sciencedirect.com/science/article/abs/pii/S0886335019303153
• Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD. "Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital." Ophthalmology, 2016 https://pubmed.ncbi.nlm.nih.gov/26522705/
• Ravilla T, Ramasamy D. "Efficient high-volume cataract services: the Aravind model." Community Eye Health, 2014 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069777/
• Gupta S, Palsule-Desai OD, Gnanasekaran C, Ravilla T. "Spillover Effects of Mission Activities on Revenues in Nonprofit Health Care." Journal of Marketing Research, 2018 https://journals.sagepub.com/doi/abs/10.1177/0022243718813347
• Lions Aravind Institute of Community Ophthalmology (LAICO) https://www.laico.org/about-us
• Aurolab https://aravind.org/aurolab/

Send us Fan Mail

Operational Velocity is for education and general information only and is not investment, financial, legal, or tax advice, and nothing in it is a recommendation to buy or sell any security. The views expressed are the host's own, the company and figures discussed are drawn from public sources believed reliable but not guaranteed, and you should do your own research and consult a qualified professional before making any decision.